Dividend Safety Check: Income After GENZ Pivot, 2026
VanEck’s gaming-focused ETF has rebranded to GENZ, shifting to digital-native growth and altering the dividend safety...
Evaluate whether the S&P 500 or total market index better suits your retirement goals, considering risk, fees, and long-term growth.
28,526 articlesVanEck’s gaming-focused ETF has rebranded to GENZ, shifting to digital-native growth and altering the dividend safety...
Investors are weighing two value plays: VLUE leans on the value factor itself, while VTV sticks with mega-cap, discou...
Institutional moves are reshaping exposure to China as the market resets. This article explains what happened with mi...
As AI expands, the backbone—data centers and compute—becomes a focal point for investors. This guide compares CoreWea...
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Choosing the right pharmaceutical ETF can shape your portfolio’s risk and income. This guide pits IHE against PJP, br...
When a billionaire investor opens a new fund, it sends ripples through markets. Bill Ackman just gave investors a fre...
A fresh retirement rule laid out on a March 2026 podcast reframes how affluent savers think about income in retiremen...
Celebrity wedding rumors can reveal practical money lessons. This guide translates the buzz around Taylor Swift Travi...
Can a defense-focused ETF outperform a jet-fueled recovery play in 2026? This deep dive examines PPA and JETS, weighi...
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
Schwab U.S. Dividend Equity ETF SCHD has moved to a more top-heavy stance, with the top 10 holdings nearing 41% of as...